Showing results (51-60 of 499) with videos related to
Sort By:
Pageof 50
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2023
Higher plasma β-synuclein indicates early synaptic degeneration in Alzheimer's diseasePatrick Oeckl, Shorena Janelidze, Steffen Halbgebauer, et al.Acta Neuropathologica Communications|August 28, 2014
Protease-resistant SOD1 aggregates in amyotrophic lateral sclerosis demonstrated by paraffin-embedded tissue (PET) blotPetra Steinacker, Christian Berner, Dietmar R Thal, et al.International Journal of Molecular Sciences|August 13, 2015
Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?Ahmed Abdelhak, Andreas Junker, Johannes Brettschneider, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|August 30, 2021
Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegenerationNerea Gómez de San José, Federico Massa, Steffen Halbgebauer, et al.Plos One|April 4, 2014
Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosisMakbule Senel, Hayrettin Tumani, Florian Lauda, et al.Acta Neuropathologica|March 26, 2018
Capillary cerebral amyloid angiopathy in Alzheimer's disease: association with allocortical/hippocampal microinfarcts and cognitive declineMoritz Hecht, Lara Maria Krämer, Christine A F von Arnim, et al.Acta Neuropathologica|November 9, 2019
Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosisPatrick Oeckl, Patrick Weydt, Dietmar R Thal, et al.Frontiers in Molecular Biosciences|May 11, 2023
Development of an ultrasensitive microfluidic assay for the analysis of Glial fibrillary acidic protein (GFAP) in bloodBadrieh Fazeli, André Huss, Nerea Gómez de San José, et al.Expert Review of Proteomics|June 1, 2017
Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studiesMhd Rami Al Shweiki, Patrick Oeckl, Petra Steinacker, et al.Seizure|May 1, 2026
Serum biomarkers of seizure-related neuronal damage and astroglial activation in epileptic seizures and epilepsyAnnemarie Thaele, Lorenzo Barba, Samir Abu-Rumeileh, et al.Pageof 50